Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$284.1M
2 rounds on record
Latest round
$142M
Venture round · Jul 2024 · 2 yr ago
Team
501-1000
employees, estimated range
Backers
1
Foresite Capital
The money's age
Long since its last round
26 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2024 $142M — SEC Form D
Venture round Jul 2024 $142M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity NGM Bio Holdings, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Kara CalhounExecutive OfficerSEC Form D
Hsiao LieuExecutive OfficerSEC Form D
David WoodhouseExecutive Officer, DirectorSEC Form D
Daniel KaplanExecutive OfficerSEC Form D
Valerie PierceExecutive OfficerSEC Form D
Jean-Frederic ViretExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Drug discovery at the resolution of biology. Using the power of the transcriptome to discover revolutionary medicines.
Boltz14 roles
Build better molecules with frontier AI models. With AI, we help every scientist reshape biology.
Abbott develops life-changing medical devices for cardiovascular conditions.
At Prellis Biologics, we harness AI and immune diversity to advance next-gen medicines. Discover our EXIS™ platform and bioprinting…
Pangea Bio11-50 employees
Developing transformative medicines for neurological and mental health disorders.
KriyatxVenture round $320.8M · 13 mo ago • 2 roles
Kriya is building durable medicines designed to replace chronic re-treatment with a single administration—therapeutic medicines that can…

Overview

Ngmbio develops life-changing medicines rooted in powerful biology, including NGM120 for hyperemesis gravidarum and cancer cachexia.

People

Kara Calhoun
Executive Officer
Hsiao Lieu
Executive Officer
David Woodhouse
Executive Officer, Director
Daniel Kaplan
Executive Officer
Valerie Pierce
Executive Officer
Jean-Frederic Viret
Executive Officer
Diana Bockus
Executive Officer, Director
Roger Perlmutter
Director
William Rieflin
Director
Shelly Guyer
Director
David Goeddel
Director
Peter Svennilson
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
South San Francisco United States
HQ
500-1000 est. staff
611 Gateway Blvd., Suite 540, South San Francisco, CA 94080
company site

Financials

Total raised
$284.1M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $142M Details
Venture - Series Unknown 2024 $142M Details